Binding of Sulfonamides to Erythrocytes and Their Components
スポンサーリンク
概要
- 論文の詳細を見る
Binding of zonisamide, a new antiepileptic sulfonamide derivative, was examined to human erythrocytes, their lysate and their carbonic anhydrase by centrifugation for cells or by ultrafiltration for the others. Scatchard plots revealed that the binding to intact and lysed cells was composed of high- and low-affinity components and that to carbonic anhydrase, of the high-affinity component alone. Parameters for high-affinity binding were similar in all three preparations and those for low-affinity binding were similar in the former two preparations. Dissociation constants for these bindings to erythrocytes were smaller than the dissociation constant for serum albumin. These results may explain the concentration of sulfonamides in red cells, and suggest the participation of cellular protein component(s) in addition to previously known carbonic anhydrase in the binding.Acetazolamide, sulthiame, zonisamide, hydrochlorothiazide and sulfanilamide inhibited carbonic anhydrase in a non-competitive manner to different extents. The K_i values of these sulfonamides were of the order of 0.1-0.2 of their respective K_d values determined by ultrafiltration, suggesting that under the present conditions, physicochemical interactions between sulfonamides and carbonic anhydrase primarily occur at common sites that affect the activity of the enzyme.
- 公益社団法人日本薬学会の論文
- 1989-07-25
著者
-
藤井 敏彦
大日本製薬・薬物動態研
-
松本 堅志
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
宮崎 亀
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
藤井 敏彦
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
橋本 昌久
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
松本 堅志
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
宮崎 亀
大日本製薬・薬物動態研
-
橋本 昌久
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
関連論文
- [^C]Ureaの体内動態(第2報) : 非絶食ラットにおける吸収,分布,,代謝,排泄
- [^C]Ureaの体内動態(第1報) : 絶食ラットにおける吸収,分布,代謝,排泄
- 抗ヒスタミン薬エバスチンの臨床薬理試験 : 認知機能検査による眠気の評価
- 新規カルシウム拮抗剤モナテピルの血漿中動態とα_1-酸性糖蛋白質濃度
- キノロン系合成抗菌剤とラット肝CYP1A2との分子間相互作用:核磁気共鳴法による検討
- [^C]Ureaの体内動態(第3報) : ラットにおける胎児および乳汁中への移行
- Binding of Sulfonamides to Erythrocyte Proteins and Possible Drug-Drug Interaction
- 抗ヒスタミン薬エバスチンの臨床薬理試験 : Positron Emission Tomography(PET)による脳内移行の評価
- 抗ヒスタミン薬エバスチンの代謝における新規ヒト小腸チトクロームP450の役割
- ラットにおけるクエン酸モサプリドの体内動態の系統差
- Posatirelinの体内動態(第3報) : ラットにおける代謝物
- The Synthesis of 2-and 4-Alkoxymethylestrogens.
- ヒト肝臓および小腸における新規ヒスタミンH_1受容体拮抗薬 ebastine の代謝
- モクロベマイドの代謝に関与するヒト肝薬物代謝酵素の同定
- Posatirelinの体内動態(第2報) : ラットにおける単回静脈内投与後の胎児,乳汁中移行性および反復静脈内投与後の血漿中濃度,分布,排泄
- Posatirelinの体内動態(第1報) : ラットにおける単回静脈内投与後の血漿中濃度,組織中濃度,脳内分布および排泄
- Binding of Sulfonamides to Erythrocytes and Their Components
- Autoradiographic Evidences on the Perilobular Distribution of Dehydrocorydaline-^C in the Mouse Liver
- Studies on Sperm Capacitation. V. Characterization of Decapacitation Factor from Guinea-pig Spermatozoa
- リスザルの14C-ヒポキサンチン代謝に対するアロプリノ-ルの影響についてのオ-トラジオグラフィ的研究〔英文〕
- モルモット聴器における14C-pipemidic acidの分布
- Antianoxic Effect of Meclofenoxate related to Its Disposition
- Comparative Studies on the Metabolism of β-Dimethylaminoethanol in the Mouse Brain and Liver Following Administration of β-Dimethyl-aminoethanol and Its p-Chlorophenoxyacetate, Meclofenoxate
- Uptake by Brain and Distribution of Radioactivity after Intravenous Administration of ^C-Labelled Meclofenoxate in Mice
- Preparation of Optically Active N-Carbamylaspartic Acid.
- An Improved Method for Liquid Scintillation Counting of Biological Materials
- Metabolism of Piromidic Acid, a New Antibacterial Agent. V. Pharmacokinetics of Piromidic Acid in Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. IV. Pharmacokinetics of Piromidic Acid in Rats
- Metabolism of Piromidic Acid, a New Antibacterial Agent. III. Determination of Piromidic Acid and Its Metabolites in Blood, Urine and Bile of Rats and Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. II. In Vitro Metabolic Pathway of Piromidic Acid in Rats
- A New Route to 2-Methyl-19-norsteroids
- Lithotriptic therapy of pancreatic calculus by oral administration of trimethadione (TMO), an antiepileptic.